Related Experiment Video
Updated: May 2, 2026

12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
2.9K
Overweight in liver transplant recipients
Revista Do Colegio Brasileiro De Cirurgioes
|February 28, 2014
Summary
Overweight and obesity are common after liver transplantation, affecting over 60% of patients. This weight gain increases risks for serious health issues like diabetes and cardiovascular disease.
Area of Science:
- Hepatology
- Transplantation Medicine
- Metabolic Disorders
Background:
- Liver transplantation is a life-saving procedure, but post-transplant complications require ongoing management.
- Weight gain, including overweight and obesity, is a frequently observed issue in liver transplant recipients.
- Understanding the incidence, prevalence, and consequences of post-transplant weight gain is crucial for patient outcomes.
Purpose of the Study:
- To review the incidence and prevalence of overweight and obesity following liver transplantation.
- To identify associated risk factors for weight gain in this population.
- To describe the health consequences linked to post-transplant overweight and obesity.
Main Methods:
- A comprehensive literature review was performed.
- Databases searched included Medline/PubMed, SciELO, EMBASE, and LILACS.
- Keywords used were: liver transplantation, overweight, obesity, and weight gain.
Main Results:
- Overweight affects over 60% of liver transplant patients; obesity exceeds 20% within the first year post-surgery.
- By the third year, 60-70% of patients are overweight, with 90% exhibiting abdominal obesity.
- Associated factors include advanced age, family history, and pre-transplant weight; immunosuppressive medication's role is debated.
Conclusions:
- Significant overweight and obesity rates are prevalent after liver transplantation.
- Weight gain is associated with serious comorbidities such as steatosis, diabetes, hypertension, and cardiovascular disease.
- Further research is needed to clarify the impact of immunosuppressants and develop effective weight management strategies.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Kidney Transplant III: Nursing Management
631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K

